Dr. Mihaljevic has led Cleveland Clinic since January 2018, directing a $13 billion globally integrated healthcare system encompassing a main campus, 22 hospitals, and 275 outpatient locations across the United States and internationally. Along with 76,700 caregivers worldwide, including 5,700 physicians and scientists, he aims to make Cleveland Clinic the best place for care anywhere and the best place to work in healthcare, treating patients and caregivers like family and Cleveland Clinic as home. Prior to becoming CEO, Dr. Mihaljevic served as CEO of Cleveland Clinic Abu Dhabi from 2015 to 2017, overseeing the opening of the first U.S. multispecialty hospital replicated outside of North America and establishing its reputation for clinical excellence, patient experience, research and education. He first joined Cleveland Clinic in 2004 after serving as director of the Cardiac Surgery Research Laboratory at Boston-based Brigham and Women’s Hospital and as assistant professor of surgery at Harvard Medical School. He is the author or co-author of more than 140 peer-reviewed publications, holds a patent for a novel system for minimally invasive cardiac surgery, and is the inaugural holder of the Morton L. Mandel CEO Chair, an endowment created by a 2022 gift from the Jack, Joseph and Morton Mandel Foundation. He is also a distinguished cardiac surgeon who has performed nearly 3,000 operations, with specialization in minimally invasive and robot-assisted procedures, valve replacement and repair, and cardiac transplantation. Dr. Mihaljevic serves on the GE HealthCare board of directors, co-chairs the board of directors of the US-UAE Business Council, and serves on the boards of the Greater Cleveland Partnership and the United Way of Greater Cleveland.
